We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Merck, Sysmex Collaborate To Develop And Commercialize Blood-Based RAS Biomarker Test

News   Jun 04, 2014

 
Merck, Sysmex Collaborate To Develop And Commercialize Blood-Based RAS Biomarker Test
 
 
 

RELATED ARTICLES

Even Genetic Diversity Couldn’t Save Darwin’s Finches

News

Researchers at the University of Cincinnati found that Charles Darwin's famous finches defy what has long been considered a key to evolutionary success: genetic diversity.

READ MORE

HIV Resistance Promoted by Repeated Semen Exposure

News

Contrary to the long-held view that semen can only act as a way to transmit HIV-1 from men to women, scientists found that frequent and sustained semen exposure can change the characteristics of the circulating and vaginal tissue immune cells that are targets for infection, reducing the susceptibility to a future infection.

READ MORE

Kissing Loops Essential for Tumor Suppression

News

A team of researchers in the Marcia group at EMBL Grenoble have discovered that the tumour suppressor MEG3 adopts a complex three-dimensional structure to fulfil its function. Furthermore, they were able to fine-tune its activity by targeted manipulation of this architecture.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Genomics Research Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE